Monarch Partners Asset Management LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 168 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.

Quarter-by-quarter ownership
Monarch Partners Asset Management LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$2,226,831
+60.8%
113,788
+31.1%
0.66%
+58.2%
Q3 2022$1,385,000
+132.4%
86,785
+232.6%
0.42%
+210.4%
Q3 2020$596,000
+61.1%
26,090
+47.6%
0.13%
+48.9%
Q2 2020$370,000
+26.3%
17,680
+48.6%
0.09%
+233.3%
Q3 2018$293,000
-0.3%
11,897
-20.6%
0.03%0.0%
Q2 2018$294,000
+4.6%
14,9820.0%0.03%
+3.8%
Q1 2018$281,00014,9820.03%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders